All patients (n=412) | Glargine U300 (n=187) | Degludec (n=225) | P value | |
Non-insulin antidiabetics (%) | 30 (7.3) | 11 (5.9) | 19 (8.4) | 0.233 |
Basal insulin | ||||
Unit/day | 31.5±16.9 | 30.1±14.9 | 32.2±18.4 | 0.759 |
Unit/kg/day | 0.43±0.20 | 0.43±0.19 | 0.44±0.21 | 0.563 |
Prandial insulin | ||||
Unit/day | 23.5±16.9 | 22.5±16.1 | 23.2±16.0 | 0.603 |
Unit/kg/day | 0.33±0.23 | 0.32±0.23 | 0.33±0.20 | 0.851 |
Total insulin | ||||
Unit/day | 54.0±29.1 | 52.8±27.4 | 55.4±29.5 | 0.383 |
Unit/kg/day | 0.77±0.36 | 0.76±0.35 | 0.76±0.33 | 0.683 |
Basal/Total insulin ratio | 0.58±0.14 | 0.59±0.14 | 0.58±0.14 | 0.441 |
T1D, type 1 diabetes.